Stay updated on Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed software/version identifier was updated from **v3.5.2** to **v3.5.3**, reflecting a site or interface revision rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check10 days agoChange DetectedNew version entry on 2026-04-13 with Revision: v3.5.2, adding updates to Contacts/Locations and Study Status.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and removes the previous v3.4.3 entry.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 was added. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedOn 2026-02-12, 48 entries were added; on 2026-02-13, Contacts/Locations and Study Status sections were added. A deletion occurred on 2026-01-16.SummaryDifference0.3%

- Check74 days agoChange DetectedRevision: v3.4.2 was added to the history. The notices about government funding and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.5%

Stay in the know with updates to Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.